Literature DB >> 28649750

Vasopressin: physiology, assessment and osmosensation.

L Bankir1,2, D G Bichet3,4, N G Morgenthaler5,6.   

Abstract

Vasopressin (AVP) plays a major role in the regulation of water and sodium homeostasis by its antidiuretic action on the kidney, mediated by V2 receptors. AVP secretion is stimulated by a rise in plasma osmolality, a decline in blood volume or stress. V1a receptors are expressed in vascular smooth muscle cells, but the role of vasopressin in blood pressure regulation is still a matter of debate. AVP may also play a role in some metabolic pathways, including gluconeogenesis, through its action on V1a receptors expressed in the liver. It is now understood that thirst and arginine vasopressin (AVP) release are regulated not only by the classical homeostatic, intero-sensory plasma osmolality negative feedback, but also by novel, extero-sensory, anticipatory signals. AVP measurement is time-consuming, and AVP level in the blood in the physiological range is often below the detection limit of the assays. Recently, an immunoassay has been developed for the measurement of copeptin, a fragment of the pre-provasopressin molecule that is easier to measure. It has been shown to be a good surrogate marker of AVP.
© 2017 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  copeptin; hypothalamus; kidney; osmolality; thirst; vasopressin receptors

Mesh:

Substances:

Year:  2017        PMID: 28649750     DOI: 10.1111/joim.12645

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  51 in total

1.  Comparison between men and women of volume regulating hormones and aquaporin-2 excretion following graded central hypovolemia.

Authors:  Nandu Goswami; Johannes Reichmuth; Annarita Di Mise; Bianca Brix; Andreas Roessler; Mariangela Centrone; Marianna Ranieri; Annamaria Russo; Natale Gaspare De Santo; Grazia Tamma; Ferdinando Carlo Sasso; Giovanna Valenti
Journal:  Eur J Appl Physiol       Date:  2018-12-18       Impact factor: 3.078

2.  Osmoregulation Performance and Kidney Transplant Outcome.

Authors:  Manal Mazloum; Jordan Jouffroy; François Brazier; Christophe Legendre; Antoine Neuraz; Nicolas Garcelon; Dominique Prié; Dany Anglicheau; Frank Bienaimé
Journal:  J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 10.121

3.  Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.

Authors:  Jeremy A Sandgren; Danny W Linggonegoro; Shao Yang Zhang; Sarah A Sapouckey; Kristin E Claflin; Nicole A Pearson; Mariah R Leidinger; Gary L Pierce; Mark K Santillan; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-01-24       Impact factor: 3.619

4.  The Cascade System of Osmotic Homeostasis Regulation.

Authors:  Yu V Natochin; A S Marina; E I Shakhmatova
Journal:  Dokl Biol Sci       Date:  2020-04-27

5.  The Mechanism of the Solute-Free Water Reabsorption Increase in the Rat Kidney by Oxytocin Saluresis.

Authors:  Yu V Natochin; E I Shakhmatova; A E Bogolepova
Journal:  Dokl Biochem Biophys       Date:  2021-03-05       Impact factor: 0.788

6.  Heritability and individuality of the plasma sodium concentration: a twin study in the United States veteran population.

Authors:  Andrew K Timmons; Anna M Korpak; Jenny Tan; Kathryn P Moore; Cindy H Liu; Christopher W Forsberg; Jack Goldberg; Nicholas L Smith; David M Cohen
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-25

7.  The contribution of collecting duct NOS1 to the concentrating mechanisms in male and female mice.

Authors:  Luciano D Mendoza; Kelly A Hyndman
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

8.  Biological variation of arginine vasopressin.

Authors:  Kurt J Sollanek; Jeffery S Staab; Robert W Kenefick; Samuel N Cheuvront
Journal:  Eur J Appl Physiol       Date:  2020-01-22       Impact factor: 3.078

9.  Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.

Authors:  Louis Potier; Ronan Roussel; Michel Marre; Petter Bjornstad; David Z Cherney; Ray El Boustany; Frédéric Fumeron; Nicolas Venteclef; Jean-François Gautier; Samy Hadjadj; Kamel Mohammedi; Gilberto Velho
Journal:  Diabetes Care       Date:  2019-10-03       Impact factor: 19.112

Review 10.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.